Analysis of changes in age of initiation of illicit drug use in Australia
Research shows that earlier initiation of drug use is associated with a range of adverse outcomes later in life including problematic substance use patterns, the use of other illicit drugs, engaging in risk behaviours, greater involvement in criminal activity and completion of fewer years of education.
The National Drug Strategy Household Survey (NDSHS) is a representative population sample of Australians that asks about illicit drug use. Analyses of the 1998 NDSHS data found that more recent age cohorts (i.e. younger Australians) were significantly more likely to have initiated a range of drugs (including cannabis, amphetamines, heroin and LSD) by 15 years of age and they had a lower mean age of first drug use compared to their older counterparts. The study also found increased recent use of illicit drugs among the younger birth cohorts.
There have been many changes in illicit drug markets in Australia since the late 1990s including increasing prevalence of amphetamine and methamphetamine use and declines in cannabis use across all age cohorts, but most dramatically among the younger birth cohorts.
This project is open to students
Update data and monitor trends
The objective is to update analysis of NDSHS survey data over time (2001 to 2022) to monitor trends in age of initiation and prevalence of illicit drug use by birth cohort over time among Australians.
Open to
- Honours
- Masters by research
Supervisors
More student projects
View 62 moreSyphilis point‐of‐care diagnostic test: diagnosis of active syphilis
We're developing point-of-care diagnostics for active syphilis, aiming to transform syphilis management globally and contribute to World Health Organization goals.
Protektem Pikinini Blong Yu: Preventing mother-to-child transmission of hepatitis B in Vanuatu
This field trial compares the effectiveness of WHO-based viral load testing guidelines to an alternative model of care.
Methamphetamine use in Melbourne and rural Victoria: the VMAX cohort study
The VMAX cohort study follows 850 people who use methamphetamine recruited from metropolitan Melbourne and 3 regions of rural Victoria.
Project contacts
Student supervisor contacts
Professor Paul Dietze
Program Director, Disease Elimination; Professor and Program Leader, National Drug Research Institute (NDRI)
Project team
Dr Amanda Roxburgh
Senior Research Fellow
Professor Paul Dietze
Program Director, Disease Elimination; Professor and Program Leader, National Drug Research Institute (NDRI)
Why study at Burnet?
When you study at Burnet, you broaden your impact working across our three Institute-wide programs: Disease Elimination; Health Security and Pandemic Preparedness; Maternal, Child and Adolescent Health.
Train with internationally recognised experts in a structured student support system, and gain a holistic research experience along the way.